The global Drug Discovery Informatics market was valued at US$ 1 million in 2023 and is anticipated to reach US$ 1 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Informatics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Informatics.
Report Scope
The Drug Discovery Informatics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Informatics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Informatics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
厂肠丑谤枚诲颈苍驳别谤
Dassault Syst猫mes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics
Segment by Type
Software
Services
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Informatics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Drug Discovery Informatics 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.3 麻豆原创 by Application
1.3.1 Global Drug Discovery Informatics 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Informatics 麻豆原创 Perspective (2019-2030)
2.2 Drug Discovery Informatics Growth Trends by Region
2.2.1 Global Drug Discovery Informatics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Informatics Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Drug Discovery Informatics Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Drug Discovery Informatics 麻豆原创 Dynamics
2.3.1 Drug Discovery Informatics Industry Trends
2.3.2 Drug Discovery Informatics 麻豆原创 Drivers
2.3.3 Drug Discovery Informatics 麻豆原创 Challenges
2.3.4 Drug Discovery Informatics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Informatics Players by Revenue
3.1.1 Global Top Drug Discovery Informatics Players by Revenue (2019-2024)
3.1.2 Global Drug Discovery Informatics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drug Discovery Informatics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Informatics Revenue
3.4 Global Drug Discovery Informatics 麻豆原创 Concentration Ratio
3.4.1 Global Drug Discovery Informatics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Informatics Revenue in 2023
3.5 Drug Discovery Informatics Key Players Head office and Area Served
3.6 Key Players Drug Discovery Informatics Product Solution and Service
3.7 Date of Enter into Drug Discovery Informatics 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Informatics Breakdown Data by Type
4.1 Global Drug Discovery Informatics Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Drug Discovery Informatics Forecasted 麻豆原创 Size by Type (2025-2030)
5 Drug Discovery Informatics Breakdown Data by Application
5.1 Global Drug Discovery Informatics Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Drug Discovery Informatics Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Informatics 麻豆原创 Size (2019-2030)
6.2 North America Drug Discovery Informatics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Discovery Informatics 麻豆原创 Size by Country (2019-2024)
6.4 North America Drug Discovery Informatics 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Informatics 麻豆原创 Size (2019-2030)
7.2 Europe Drug Discovery Informatics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Discovery Informatics 麻豆原创 Size by Country (2019-2024)
7.4 Europe Drug Discovery Informatics 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Informatics 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Drug Discovery Informatics 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Discovery Informatics 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Drug Discovery Informatics 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Informatics 麻豆原创 Size (2019-2030)
9.2 Latin America Drug Discovery Informatics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Discovery Informatics 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Drug Discovery Informatics 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Informatics 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Drug Discovery Informatics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Discovery Informatics 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Drug Discovery Informatics 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Drug Discovery Informatics Introduction
11.1.4 IBM Revenue in Drug Discovery Informatics Business (2019-2024)
11.1.5 IBM Recent Development
11.2 Infosys
11.2.1 Infosys Company Detail
11.2.2 Infosys Business Overview
11.2.3 Infosys Drug Discovery Informatics Introduction
11.2.4 Infosys Revenue in Drug Discovery Informatics Business (2019-2024)
11.2.5 Infosys Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Drug Discovery Informatics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Drug Discovery Informatics Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer Drug Discovery Informatics Introduction
11.4.4 Perkinelmer Revenue in Drug Discovery Informatics Business (2019-2024)
11.4.5 Perkinelmer Recent Development
11.5 厂肠丑谤枚诲颈苍驳别谤
11.5.1 厂肠丑谤枚诲颈苍驳别谤 Company Detail
11.5.2 厂肠丑谤枚诲颈苍驳别谤 Business Overview
11.5.3 厂肠丑谤枚诲颈苍驳别谤 Drug Discovery Informatics Introduction
11.5.4 厂肠丑谤枚诲颈苍驳别谤 Revenue in Drug Discovery Informatics Business (2019-2024)
11.5.5 厂肠丑谤枚诲颈苍驳别谤 Recent Development
11.6 Dassault Syst猫mes
11.6.1 Dassault Syst猫mes Company Detail
11.6.2 Dassault Syst猫mes Business Overview
11.6.3 Dassault Syst猫mes Drug Discovery Informatics Introduction
11.6.4 Dassault Syst猫mes Revenue in Drug Discovery Informatics Business (2019-2024)
11.6.5 Dassault Syst猫mes Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Detail
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Drug Discovery Informatics Introduction
11.7.4 Charles River Laboratories Revenue in Drug Discovery Informatics Business (2019-2024)
11.7.5 Charles River Laboratories Recent Development
11.8 Selvita
11.8.1 Selvita Company Detail
11.8.2 Selvita Business Overview
11.8.3 Selvita Drug Discovery Informatics Introduction
11.8.4 Selvita Revenue in Drug Discovery Informatics Business (2019-2024)
11.8.5 Selvita Recent Development
11.9 Certara
11.9.1 Certara Company Detail
11.9.2 Certara Business Overview
11.9.3 Certara Drug Discovery Informatics Introduction
11.9.4 Certara Revenue in Drug Discovery Informatics Business (2019-2024)
11.9.5 Certara Recent Development
11.10 GVK Biosciences
11.10.1 GVK Biosciences Company Detail
11.10.2 GVK Biosciences Business Overview
11.10.3 GVK Biosciences Drug Discovery Informatics Introduction
11.10.4 GVK Biosciences Revenue in Drug Discovery Informatics Business (2019-2024)
11.10.5 GVK Biosciences Recent Development
11.11 Collaborative Drug Discovery
11.11.1 Collaborative Drug Discovery Company Detail
11.11.2 Collaborative Drug Discovery Business Overview
11.11.3 Collaborative Drug Discovery Drug Discovery Informatics Introduction
11.11.4 Collaborative Drug Discovery Revenue in Drug Discovery Informatics Business (2019-2024)
11.11.5 Collaborative Drug Discovery Recent Development
11.12 Openeye Scientific Software
11.12.1 Openeye Scientific Software Company Detail
11.12.2 Openeye Scientific Software Business Overview
11.12.3 Openeye Scientific Software Drug Discovery Informatics Introduction
11.12.4 Openeye Scientific Software Revenue in Drug Discovery Informatics Business (2019-2024)
11.12.5 Openeye Scientific Software Recent Development
11.13 IO Informatics
11.13.1 IO Informatics Company Detail
11.13.2 IO Informatics Business Overview
11.13.3 IO Informatics Drug Discovery Informatics Introduction
11.13.4 IO Informatics Revenue in Drug Discovery Informatics Business (2019-2024)
11.13.5 IO Informatics Recent Development
11.14 Novo Informatics
11.14.1 Novo Informatics Company Detail
11.14.2 Novo Informatics Business Overview
11.14.3 Novo Informatics Drug Discovery Informatics Introduction
11.14.4 Novo Informatics Revenue in Drug Discovery Informatics Business (2019-2024)
11.14.5 Novo Informatics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
厂肠丑谤枚诲颈苍驳别谤
Dassault Syst猫mes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics
听
听
*If Applicable.
